While generics may dominate due to cost advantages and meeting needs of a developing economy, there is a growing thrust ...

“I definitely didn’t foresee that there’ll be so many fires to put out,” says the head of HR at BASF. “There’s a lot of ...

This recognition is a testament to the culture of collaboration ... approved in Canada for the treatment of myelofibrosis in adults who have moderate to severe anemia GSK announced today that Health ...

GlaxoSmithKline’s (GSK ... expansive capabilities, client focus and culture make it a unique platform from which to advance health care worldwide, so I am incredibly excited to be part of ...

By enhancing DEI strategies, UK firms can set themselves apart, fostering inclusivity that drives growth – Reshma Sheikh explains As major US firms like Harley Davidson, Brown-Forman and Molson Coors ...

Gilead Sciences Canada, Inc. (Gilead Canada) announced today that Paul Petrelli joined the organization as Vice President and General Manager. In his new role, Petrelli will be responsible for leading ...

Prior to that role, Ms. Koehler led innovation and product management for Ontex in North America where she delivered ...

Welcome to the Moderna third quarter 2024 conference call. [Operator instructions] Please be advised today's conference is ...

BMI, a Fitch Solutions company, has predicted that the naira would slide to as low as N1,993 to one US dollar in 2028, ...

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing. Influenza causes 140,000 to ...

GSK’s Trelegy, a treatment for chronic obstructive pulmonary disease (COPD), aimed to address a gap in the market with its ...